(UBS) UBS - Overview
Sector: Financial ServicesIndustry: Banks - Diversified | Exchange NYSE (USA) | Currency USD | Market Cap: 116.055m | Total Return 17.7% in 12m
Stock: Banking, Wealth Management, Investments, Lending, Advisory
Total Rating 38
Risk 40
Buy Signal -0.55
| Risk 5d forecast | |
|---|---|
| Volatility | 30.1% |
| Relative Tail Risk | -0.72% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 0.56 |
| Alpha | 0.91 |
| Character TTM | |
|---|---|
| Beta | 1.194 |
| Beta Downside | 0.769 |
| Drawdowns 3y | |
|---|---|
| Max DD | 27.00% |
| CAGR/Max DD | 1.00 |
EPS (Earnings per Share)
Revenue
Description: UBS UBS March 06, 2026
UBS Group AG is a diversified financial services company based in Switzerland. It provides financial advice and solutions to private, institutional, and corporate clients globally.
The company operates through five divisions, including Global Wealth Management and an Investment Bank. Wealth management services include estate planning and investment advice. Investment banking typically involves capital raising and mergers and acquisitions advisory.
UBS offers various banking products, such as mortgages, credit cards, and online banking. It also provides corporate and institutional solutions, including equity and debt capital markets, and transaction banking services.
Additionally, UBS offers asset management services, covering equities, fixed income, hedge funds, and real estate. The firm engages in securities trading, financing, and risk management across various asset classes.
To further understand UBSs market position and financial performance, consider exploring detailed analyst reports and financial models available on ValueRay.
Headlines to watch out for
- Global wealth management fees drive substantial revenue growth
- Investment banking activity impacts trading and advisory income
- Interest rate fluctuations influence net interest margin
- Regulatory fines and litigation costs erode profitability
- Economic downturns reduce client assets under management
Piotroski VR‑10 (Strict, 0-10) 3.5
| Net Income: 6.27b TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.00 > 0.02 and ΔFCF/TA 0.15 > 1.0 |
| NWC/Revenue: -985.4% < 20% (prev -812.4%; Δ -173.0% < -1%) |
| CFO/TA 0.00 > 3% & CFO 6.17b > Net Income 6.27b |
| Net Debt (91.78b) to EBITDA (9.94b): 9.24 < 3 |
| Current Ratio: 0.42 > 1.5 & < 3 |
| Outstanding Shares: last quarter (3.31b) vs 12m ago -0.88% < -2% |
| Gross Margin: 63.36% > 18% (prev 0.55%; Δ 6.28k% > 0.5%) |
| Asset Turnover: 3.94% > 50% (prev 5.12%; Δ -1.18% > 0%) |
| Interest Coverage Ratio: 0.33 > 6 (EBITDA TTM 9.94b / Interest Expense TTM 21.48b) |
Altman Z'' -2.13
| A: -0.36 (Total Current Assets 434.00b - Total Current Liabilities 1023.20b) / Total Assets 1617.43b |
| B: 0.05 (Retained Earnings 82.74b / Total Assets 1617.43b) |
| C: 0.00 (EBIT TTM 7.16b / Avg Total Assets 1519.03b) |
| D: 0.06 (Book Value of Equity 88.89b / Total Liabilities 1526.94b) |
| Altman-Z'' Score: -2.13 = D |
Beneish M -3.15
| DSRI: 1.23 (Receivables 35.58b/35.29b, Revenue 59.79b/72.69b) |
| GMI: 0.87 (GM 63.36% / 55.21%) |
| AQI: 0.88 (AQ_t 0.72 / AQ_t-1 0.82) |
| SGI: 0.82 (Revenue 59.79b / 72.69b) |
| TATA: 0.00 (NI 6.27b - CFO 6.17b) / TA 1617.43b) |
| Beneish M-Score: -3.15 (Cap -4..+1) = AA |
What is the price of UBS shares?
As of March 27, 2026, the stock is trading at USD 37.26 with a total of 2,626,076 shares traded.
Over the past week, the price has changed by -0.27%, over one month by -11.07%, over three months by -21.18% and over the past year by +17.68%.
Over the past week, the price has changed by -0.27%, over one month by -11.07%, over three months by -21.18% and over the past year by +17.68%.
Is UBS a buy, sell or hold?
UBS has received a consensus analysts rating of 2.50.
Therefor, it is recommend to sell UBS.
- StrongBuy: 0
- Buy: 0
- Hold: 1
- Sell: 1
- StrongSell: 0
What are the forecasts/targets for the UBS price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 51.2 | 37.3% |
| Analysts Target Price | 51.2 | 37.3% |
UBS Fundamental Data Overview March 23, 2026
P/E Trailing = 15.5636
P/E Forward = 11.8203
P/S = 2.34
P/B = 1.2588
P/EG = 0.441
Revenue TTM = 59.79b USD
EBIT TTM = 7.16b USD
EBITDA TTM = 9.94b USD
Long Term Debt = 328.50b USD (from longTermDebt, last quarter)
Short Term Debt = 39.71b USD (from shortTermDebt, last quarter)
Debt = 301.63b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 91.78b USD (from netDebt column, last quarter)
Enterprise Value = 19.26b USD (116.05b + Debt 301.63b - CCE 398.43b)
Interest Coverage Ratio = 0.33 (Ebit TTM 7.16b / Interest Expense TTM 21.48b)
EV/FCF = 4.89x (Enterprise Value 19.26b / FCF TTM 3.94b)
FCF Yield = 20.43% (FCF TTM 3.94b / Enterprise Value 19.26b)
FCF Margin = 6.58% (FCF TTM 3.94b / Revenue TTM 59.79b)
Net Margin = 10.48% (Net Income TTM 6.27b / Revenue TTM 59.79b)
Gross Margin = 63.36% ((Revenue TTM 59.79b - Cost of Revenue TTM 21.91b) / Revenue TTM)
Gross Margin QoQ = 65.46% (prev 63.90%)
Tobins Q-Ratio = 0.01 (Enterprise Value 19.26b / Total Assets 1617.43b)
Interest Expense / Debt = 1.63% (Interest Expense 4.91b / Debt 301.63b)
Taxrate = 29.12% (392.6m / 1.35b)
NOPAT = 5.07b (EBIT 7.16b * (1 - 29.12%))
Current Ratio = 0.42 (Total Current Assets 434.00b / Total Current Liabilities 1023.20b)
Debt / Equity = 3.34 (Debt 301.63b / totalStockholderEquity, last quarter 90.21b)
Debt / EBITDA = 9.24 (Net Debt 91.78b / EBITDA 9.94b)
Debt / FCF = 23.32 (Net Debt 91.78b / FCF TTM 3.94b)
Total Stockholder Equity = 89.14b (last 4 quarters mean from totalStockholderEquity)
RoA = 0.41% (Net Income 6.27b / Total Assets 1617.43b)
RoE = 7.03% (Net Income TTM 6.27b / Total Stockholder Equity 89.14b)
RoCE = 1.71% (EBIT 7.16b / Capital Employed (Equity 89.14b + L.T.Debt 328.50b))
RoIC = 1.20% (NOPAT 5.07b / Invested Capital 424.34b)
WACC = 3.66% (E(116.05b)/V(417.69b) * Re(10.18%) + D(301.63b)/V(417.69b) * Rd(1.63%) * (1-Tc(0.29)))
Discount Rate = 10.18% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 33.33 | Cagr: 1.25%
[DCF] Terminal Value 80.82% ; FCFF base≈2.87b ; Y1≈1.88b ; Y5≈861.6m
[DCF] Fair Price = N/A (negative equity: EV 27.35b - Net Debt 91.78b = -64.43b; debt exceeds intrinsic value)
EPS Correlation: 26.36 | EPS CAGR: 2.54% | SUE: 0.39 | # QB: 0
Revenue Correlation: 69.22 | Revenue CAGR: 12.41% | SUE: 2.24 | # QB: 1
EPS next Quarter (2026-06-30): EPS=0.85 | Chg7d=+0.847 | Chg30d=+0.847 | Revisions Net=+0 | Analysts=1
EPS current Year (2026-12-31): EPS=3.16 | Chg7d=+0.350 | Chg30d=-0.030 | Revisions Net=+1 | Growth EPS=+5.1% | Growth Revenue=+3.9%
EPS next Year (2027-12-31): EPS=3.98 | Chg7d=+0.310 | Chg30d=+0.310 | Revisions Net=+1 | Growth EPS=+25.9% | Growth Revenue=+3.4%
P/E Forward = 11.8203
P/S = 2.34
P/B = 1.2588
P/EG = 0.441
Revenue TTM = 59.79b USD
EBIT TTM = 7.16b USD
EBITDA TTM = 9.94b USD
Long Term Debt = 328.50b USD (from longTermDebt, last quarter)
Short Term Debt = 39.71b USD (from shortTermDebt, last quarter)
Debt = 301.63b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 91.78b USD (from netDebt column, last quarter)
Enterprise Value = 19.26b USD (116.05b + Debt 301.63b - CCE 398.43b)
Interest Coverage Ratio = 0.33 (Ebit TTM 7.16b / Interest Expense TTM 21.48b)
EV/FCF = 4.89x (Enterprise Value 19.26b / FCF TTM 3.94b)
FCF Yield = 20.43% (FCF TTM 3.94b / Enterprise Value 19.26b)
FCF Margin = 6.58% (FCF TTM 3.94b / Revenue TTM 59.79b)
Net Margin = 10.48% (Net Income TTM 6.27b / Revenue TTM 59.79b)
Gross Margin = 63.36% ((Revenue TTM 59.79b - Cost of Revenue TTM 21.91b) / Revenue TTM)
Gross Margin QoQ = 65.46% (prev 63.90%)
Tobins Q-Ratio = 0.01 (Enterprise Value 19.26b / Total Assets 1617.43b)
Interest Expense / Debt = 1.63% (Interest Expense 4.91b / Debt 301.63b)
Taxrate = 29.12% (392.6m / 1.35b)
NOPAT = 5.07b (EBIT 7.16b * (1 - 29.12%))
Current Ratio = 0.42 (Total Current Assets 434.00b / Total Current Liabilities 1023.20b)
Debt / Equity = 3.34 (Debt 301.63b / totalStockholderEquity, last quarter 90.21b)
Debt / EBITDA = 9.24 (Net Debt 91.78b / EBITDA 9.94b)
Debt / FCF = 23.32 (Net Debt 91.78b / FCF TTM 3.94b)
Total Stockholder Equity = 89.14b (last 4 quarters mean from totalStockholderEquity)
RoA = 0.41% (Net Income 6.27b / Total Assets 1617.43b)
RoE = 7.03% (Net Income TTM 6.27b / Total Stockholder Equity 89.14b)
RoCE = 1.71% (EBIT 7.16b / Capital Employed (Equity 89.14b + L.T.Debt 328.50b))
RoIC = 1.20% (NOPAT 5.07b / Invested Capital 424.34b)
WACC = 3.66% (E(116.05b)/V(417.69b) * Re(10.18%) + D(301.63b)/V(417.69b) * Rd(1.63%) * (1-Tc(0.29)))
Discount Rate = 10.18% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 33.33 | Cagr: 1.25%
[DCF] Terminal Value 80.82% ; FCFF base≈2.87b ; Y1≈1.88b ; Y5≈861.6m
[DCF] Fair Price = N/A (negative equity: EV 27.35b - Net Debt 91.78b = -64.43b; debt exceeds intrinsic value)
EPS Correlation: 26.36 | EPS CAGR: 2.54% | SUE: 0.39 | # QB: 0
Revenue Correlation: 69.22 | Revenue CAGR: 12.41% | SUE: 2.24 | # QB: 1
EPS next Quarter (2026-06-30): EPS=0.85 | Chg7d=+0.847 | Chg30d=+0.847 | Revisions Net=+0 | Analysts=1
EPS current Year (2026-12-31): EPS=3.16 | Chg7d=+0.350 | Chg30d=-0.030 | Revisions Net=+1 | Growth EPS=+5.1% | Growth Revenue=+3.9%
EPS next Year (2027-12-31): EPS=3.98 | Chg7d=+0.310 | Chg30d=+0.310 | Revisions Net=+1 | Growth EPS=+25.9% | Growth Revenue=+3.4%